Barely Significant
← all excerpts

Assessing Torquetenovirus (TTV) as a Biomarker for Immune Responses to SARS-CoV-2 mRNA Vaccines in People Living with HIV and Healthy Individuals.

Vaccines (Basel) · 2025 · PMC11861181 · PMID 40006700

Europe PMCDOI
1
hedged sentence
0.0470
closest p · 0.9× alpha
0.0470
boldest claim

The sentences

moderately significantp = 0.047actually significant
There was no significant difference in TTV prevalence between T0 and T3, but a moderately significant difference was observed between the median TTV VL ( p = 0.047).

also in 2,182 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.